ALKS 2680, 8mg

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaNCT06767683Alkermes, Inc.Phase 2, Phase 3Recruiting2030-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.